AG˹ٷ

STOCK TITAN

[8-K] Quipt Home Medical Corp. Reports Material Event

Filing Impact
(Neutral)
Filing Sentiment
(Neutral)
Form Type
8-K
Rhea-AI Filing Summary

Quipt Home Medical Corp. announced a press release furnished on August 11, 2025 reporting its financial results for the quarter ended June 30, 2025. The filing states the press release is furnished as Exhibit 99.1 and that the information is furnished, not filed, under the Exchange Act.

The company discloses the press release includes Non-GAAP financial measures along with GAAP comparatives and reconciliations and explains management believes these measures provide useful supplemental information. The 8-K is signed by CFO Hardik Mehta and identifies Quipt as an emerging growth company incorporated in British Columbia, Canada.

Quipt Home Medical Corp. ha pubblicato un comunicato stampa fornito l'11 agosto 2025 con i risultati finanziari per il trimestre chiuso il 30 giugno 2025. Il deposito indica che il comunicato stampa è fornito come Allegato 99.1 e che l'informazione è fornita, non depositata, ai sensi dell'Exchange Act.

L'azienda dichiara che il comunicato include misure finanziarie non-GAAP insieme a confronti e riconciliazioni GAAP, spiegando che la direzione ritiene tali misure informazioni supplementari utili. Il Modulo 8-K è firmato dal CFO Hardik Mehta e identifica Quipt come emerging growth company (società in crescita emergente) costituita nella British Columbia, Canada.

Quipt Home Medical Corp. anunció un comunicado de prensa suministrado el 11 de agosto de 2025 que informa sus resultados financieros para el trimestre terminado el 30 de junio de 2025. El documento indica que el comunicado se suministra como Anexo 99.1 y que la información se suministra, no se presenta, de conformidad con la Exchange Act.

La compañía revela que el comunicado incluye medidas financieras no-GAAP junto con comparativos y conciliaciones bajo GAAP y explica que la dirección considera que estas medidas aportan información complementaria útil. El Formulario 8-K está firmado por el CFO Hardik Mehta e identifica a Quipt como una emerging growth company (empresa emergente en crecimiento) constituida en British Columbia, Canadá.

Quipt Home Medical Corp.� 2025� 8� 11일에 공시� 보도자료� 통해 2025� 6� 30� 종료 분기 실적� 보고했다� 발표했습니다. 제출서류� 해당 보도자료가 증빙자료 99.1(Exhibit 99.1)� 제공되었으며, � 정보� Exchange Act� 따라 제출� 것이 아니� 제공� �(furnished, not filed)이라� 명시합니�.

회사 측은 보도자료� �-GAAP 재무지�가 GAAP 비교수치 � 조정표와 함께 포함되어 있으�, 경영진은 이러� 지표가 유용� 보충 정보라고 판단한다� 밝힙니다. 8-K 문서� 재무책임�(CFO) Hardik Mehta가 서명했으�, Quipt� 캐나� 브리티시컬럼비아� 설립� emerging growth company(성장 초기 기업)� 명시합니�.

Quipt Home Medical Corp. a annoncé un communiqué de presse fourni le 11 août 2025 faisant état de ses résultats financiers pour le trimestre clos le 30 juin 2025. Le dépôt indique que le communiqué est fourni en tant que Annexe 99.1 et que l'information est fournie, non déposée, en vertu de l'Exchange Act.

La société précise que le communiqué contient des mesures financières non-GAAP ainsi que des comparaisons et des réconciliations selon les normes GAAP, et explique que la direction estime que ces mesures fournissent des informations complémentaires utiles. Le formulaire 8-K est signé par le directeur financier (CFO) Hardik Mehta et identifie Quipt comme une emerging growth company (entreprise émergente en croissance) constituée en Colombie-Britannique, Canada.

Quipt Home Medical Corp. gab eine am 11. August 2025 bereitgestellte Pressemitteilung bekannt, in der die Finanzergebnisse für das Quartal zum 30. Juni 2025 berichtet werden. Die Einreichung weist aus, dass die Pressemitteilung als Exhibit 99.1 bereitgestellt wurde und dass die Informationen nach dem Exchange Act "furnished, not filed" sind (bereitgestellt, nicht eingereicht).

Das Unternehmen legt offen, dass die Pressemitteilung Non-GAAP-Finanzkennzahlen zusammen mit GAAP-Vergleichszahlen und -Abstimmungen enthält und erläutert, dass das Management diese Kennzahlen für nützliche Zusatzinformationen hält. Das Formular 8-K ist vom CFO Hardik Mehta unterzeichnet und weist Quipt als in British Columbia, Kanada, gegründetes emerging growth company (wachstumsorientiertes Jungunternehmen) aus.

Positive
  • None.
Negative
  • None.

Insights

TL;DR: The 8-K furnishes Q2 2025 results press release but provides no financial figures, limiting immediate analytical conclusions.

The filing confirms a press release for the quarter ended June 30, 2025 was furnished as Exhibit 99.1 and that it contains Non-GAAP measures reconciled to GAAP. From an analyst perspective, the filing is a routine disclosure that signals upcoming data availability rather than delivering material content itself. Because no revenue, profit, guidance, or balance-sheet items are included in the 8-K text, investors must review Exhibit 99.1 to assess performance and material impact.

TL;DR: This 8-K meets disclosure and formatting expectations but is procedural; it furnishes, rather than files, the earnings release.

The document appropriately notes the press release is furnished and not deemed filed, which limits the Exchange Act liabilities associated with the content. The explicit inclusion of Non-GAAP measures with reconciliations reflects compliance with Regulation G disclosure practices. The filing identifies the company as an emerging growth company and is signed by the CFO, indicating standard internal controls over disclosure timing. Without the exhibit text, governance implications are limited.

Quipt Home Medical Corp. ha pubblicato un comunicato stampa fornito l'11 agosto 2025 con i risultati finanziari per il trimestre chiuso il 30 giugno 2025. Il deposito indica che il comunicato stampa è fornito come Allegato 99.1 e che l'informazione è fornita, non depositata, ai sensi dell'Exchange Act.

L'azienda dichiara che il comunicato include misure finanziarie non-GAAP insieme a confronti e riconciliazioni GAAP, spiegando che la direzione ritiene tali misure informazioni supplementari utili. Il Modulo 8-K è firmato dal CFO Hardik Mehta e identifica Quipt come emerging growth company (società in crescita emergente) costituita nella British Columbia, Canada.

Quipt Home Medical Corp. anunció un comunicado de prensa suministrado el 11 de agosto de 2025 que informa sus resultados financieros para el trimestre terminado el 30 de junio de 2025. El documento indica que el comunicado se suministra como Anexo 99.1 y que la información se suministra, no se presenta, de conformidad con la Exchange Act.

La compañía revela que el comunicado incluye medidas financieras no-GAAP junto con comparativos y conciliaciones bajo GAAP y explica que la dirección considera que estas medidas aportan información complementaria útil. El Formulario 8-K está firmado por el CFO Hardik Mehta e identifica a Quipt como una emerging growth company (empresa emergente en crecimiento) constituida en British Columbia, Canadá.

Quipt Home Medical Corp.� 2025� 8� 11일에 공시� 보도자료� 통해 2025� 6� 30� 종료 분기 실적� 보고했다� 발표했습니다. 제출서류� 해당 보도자료가 증빙자료 99.1(Exhibit 99.1)� 제공되었으며, � 정보� Exchange Act� 따라 제출� 것이 아니� 제공� �(furnished, not filed)이라� 명시합니�.

회사 측은 보도자료� �-GAAP 재무지�가 GAAP 비교수치 � 조정표와 함께 포함되어 있으�, 경영진은 이러� 지표가 유용� 보충 정보라고 판단한다� 밝힙니다. 8-K 문서� 재무책임�(CFO) Hardik Mehta가 서명했으�, Quipt� 캐나� 브리티시컬럼비아� 설립� emerging growth company(성장 초기 기업)� 명시합니�.

Quipt Home Medical Corp. a annoncé un communiqué de presse fourni le 11 août 2025 faisant état de ses résultats financiers pour le trimestre clos le 30 juin 2025. Le dépôt indique que le communiqué est fourni en tant que Annexe 99.1 et que l'information est fournie, non déposée, en vertu de l'Exchange Act.

La société précise que le communiqué contient des mesures financières non-GAAP ainsi que des comparaisons et des réconciliations selon les normes GAAP, et explique que la direction estime que ces mesures fournissent des informations complémentaires utiles. Le formulaire 8-K est signé par le directeur financier (CFO) Hardik Mehta et identifie Quipt comme une emerging growth company (entreprise émergente en croissance) constituée en Colombie-Britannique, Canada.

Quipt Home Medical Corp. gab eine am 11. August 2025 bereitgestellte Pressemitteilung bekannt, in der die Finanzergebnisse für das Quartal zum 30. Juni 2025 berichtet werden. Die Einreichung weist aus, dass die Pressemitteilung als Exhibit 99.1 bereitgestellt wurde und dass die Informationen nach dem Exchange Act "furnished, not filed" sind (bereitgestellt, nicht eingereicht).

Das Unternehmen legt offen, dass die Pressemitteilung Non-GAAP-Finanzkennzahlen zusammen mit GAAP-Vergleichszahlen und -Abstimmungen enthält und erläutert, dass das Management diese Kennzahlen für nützliche Zusatzinformationen hält. Das Formular 8-K ist vom CFO Hardik Mehta unterzeichnet und weist Quipt als in British Columbia, Kanada, gegründetes emerging growth company (wachstumsorientiertes Jungunternehmen) aus.

00-00000000001540013false00015400132025-08-112025-08-11

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

FORM 8-K

CURRENT REPORT

Pursuant to Section 13 or 15(d) of

The Securities Exchange Act of 1934

August 11, 2025

Date of Report (Date of earliest event reported)

Quipt Home Medical Corp.

(Exact name of registrant as specified in its charter)

British Columbia, Canada

(State or other jurisdiction of incorporation)

001-40413

    

N/A

(Commission File Number)

(IRS Employer Identification No.)

1019 Town Drive

    

Wilder, Kentucky

41076

(Address of principal executive offices)

(Zip Code)

(859) 878-2220

(Registrant’s telephone number, including area code)

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:

 Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

 Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

 Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

 Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

Securities registered pursuant to Section 12(b) of the Act:

Title of each class

    

Trading Symbol(s)

    

Name of each exchange on which registered

Common Shares, without Par Value

QIPT

The Nasdaq Capital Market

Toronto Stock Exchange

Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§ 230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§ 240.12b-2 of this chapter).

Emerging growth company   

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act.   

Item 2.02. Results of Operations and Financial Condition.

On August 11, 2025, Quipt Home Medical Corp. (the “Company”) issued a press release regarding the Company’s financial results for the quarter ended June 30, 2025. A copy of that press release is furnished as Exhibit 99.1 hereto and incorporated herein by reference.

The information in this Item 2.02, including Exhibit 99.1 hereto, is furnished and shall not be deemed “filed” for purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the “Exchange Act”), or otherwise subject to the liabilities of that section. The information contained herein and in the accompanying exhibit is not incorporated by reference in any filing of the Company under the Securities Act of 1933, as amended, or the Exchange Act, whether made before or after the date hereof, except as shall be expressly set forth by specific reference in such a filing. The press release includes Non-GAAP financial measures as defined in Regulation G.

Use of Non-GAAP Financial Information:

The press release also includes the most directly comparable financial measures calculated and presented in accordance with accounting principles generally accepted in the United States (“GAAP”), information reconciling the Non-GAAP financial measures to the GAAP financial measures and a discussion of the reasons why the Company’s management believes that presentation of the Non-GAAP financial measures provides useful information to investors regarding the Company’s financial condition and results of operations. The Non-GAAP financial measures presented therein should be considered in addition to, not as a substitute for, or superior to, financial measures calculated and presented in accordance with GAAP.

Item 9.01. Financial Statements and Exhibits.

(d) Exhibits.

Exhibit No.

    

Description

99.1

Press Release by Quipt Home Medical Corp. dated August 11, 2025.

104

Cover Page Interactive Data File, formatted in Inline XBRL and included as Exhibit 101.

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

Quipt Home Medical Corp.

Date:

August 11, 2025

By:

/s/ Hardik Mehta

Hardik Mehta

Chief Financial Officer

FAQ

When did Quipt (QIPT) report results for the quarter ended June 30, 2025?

Quipt issued a press release dated August 11, 2025 reporting results for the quarter ended June 30, 2025, furnished as Exhibit 99.1.

Does the 8-K include the company’s financial numbers for Q2 2025?

No. The 8-K states a press release containing the results is furnished as Exhibit 99.1, but the filing text itself does not include financial figures.

Are Non-GAAP financial measures included in the disclosed press release?

Yes. The filing states the press release includes Non-GAAP financial measures and provides reconciliations to the most directly comparable GAAP measures.

Is the press release considered "filed" under the Exchange Act?

No. The 8-K explicitly states the information and Exhibit 99.1 are furnished and shall not be deemed "filed" for purposes of Section 18 of the Exchange Act.

What is Quipt’s corporate status and who signed the 8-K?

Quipt is incorporated in British Columbia, Canada, is designated an emerging growth company, and the form is signed by Hardik Mehta, Chief Financial Officer.
Quipt Home Medical Corp

NASDAQ:QIPT

QIPT Rankings

QIPT Latest News

QIPT Latest SEC Filings

QIPT Stock Data

97.75M
36.56M
15.27%
56.75%
2.39%
Medical Distribution
Services-misc Health & Allied Services, Nec
United States
WILDER